Immune Dysregulation in Uremia

尿毒症的免疫失调

基本信息

  • 批准号:
    8505480
  • 负责人:
  • 金额:
    $ 15.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-15 至 2015-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic kidney failure, also known as end-stage renal disease (ESRD), results in the build-up of waste toxins that affect organs and tissues throughout the body, and causes significant mortality. The most common cause of death in chronic kidney failure is cardiovascular disease that results from chronic inflammation. Infections are the second most common cause of death in patients with ESRD, suggesting that ESRD results in alterations to the immune system. Previous attempts to understand these changes in immune function have focused on the characterization of circulating immune cells from relatively small numbers of patients with ESRD. As such, these studies are limited by multiple different causes for the kidney failure, and it is often not possible to distinguish the effect of kidney failure frm the effects of the dialysis used to replace kidney function. In order to gain a better understanding of the primary effect of kidney failure on immune function it may be valuable to use an experimentally reproducible model system. For this proposal, the well-established and reproducible mouse model of ESRD represented by 5/6 nephrectomy (SNx) will be used. In this proposal's first specific aim, macrophages, a key cell in the innate immune system, will be isolated from SNx and control mice. These macrophages will be examined in tissue culture to understand how chronic kidney failure primes the innate immune system to generate excess pro-inflammation. In the second specific aim, T- lymphocytes, the cell type responsible for directing immune responses, will be isolated from SNx and control mice, and examined in tissue culture to understand how chronic kidney failure alters adaptive immune responses. In the third specific aim, the immune systems of SNx and control mice will be challenged in vivo with the fungus Aspergillus fumigatus, which will serve as a model organism to probe pro-inflammatory immune responses that depend upon the coordinated activity of both innate and adaptive immunity. In all three aims, experiments will be conducted to isolate nuclear DNA from immune system cells to determine if the difference in their responses will be reflected in acquired modifications to their DNA (i.e. epigenetic alterations). The information gained from these studies is a first step in order to better understand how chronic kidney failure alters immune function, and how these alterations contribute to the high mortality in ESRD. Ultimately, it is hoped that these studies will lead to the development of new methods to reset immune responses in ESRD, and help to prevent both cardiovascular disease and lethal infections.
描述(由申请人提供):慢性肾衰竭,也称为终末期肾病(ESRD),导致堆积的废物毒素会影响整个身体的器官和组织,并导致重大死亡。慢性肾衰竭的最常见死亡原因是慢性炎症引起的心血管疾病。感染是ESRD患者的第二大常见死亡原因,这表明ESRD会导致免疫系统改变。以前的尝试了解免疫功能变化的尝试集中在相对较少的ESRD患者中循环中的免疫细胞的表征。因此,这些研究受到肾衰竭的多种不同原因的限制,通常不可能区分肾衰竭的作用,而肾脏衰竭的作用是用于替代肾脏功能的透析的影响。为了更好地了解肾衰竭对免疫功能的主要影响,使用实验可重复的模型系统可能很有价值。为此,将使用由5/6肾切除术(SNX)代表的ESRD的良好和可重复的小鼠模型。在该提案的第一个特定目的中,将从SNX和对照小鼠中隔离巨噬细胞,即先天免疫系统中的关键细胞。这些巨噬细胞将在组织培养中进行检查,以了解慢性肾衰竭如何在先天免疫系统中产生过量的促炎。在第二个特定目的中,T-淋巴细胞(负责指导免疫反应的细胞类型)将从SNX和对照小鼠中分离出来,并在组织培养中进行检查,以了解慢性肾衰竭如何改变适应性免疫反应。在第三个特定目的中,SNX和对照小鼠的免疫系统将在体内与真菌曲霉菌富马图斯(Aspergillus fumigatus)在体内受到挑战,该曲霉将作为模型生物体,以探测取决于先天性和适应性免疫的协调活性的促炎性免疫反应。在所有三个目的中,将进行实验,以分离免疫系统细胞的核DNA,以确定其反应的差异是否会反映在获得对其DNA的修改中(即表观遗传改变)。从这些研究中获得的信息是第一步,以便更好地了解慢性肾衰竭如何改变免疫功能,以及这些改变如何促进ESRD的高死亡率。最终,希望这些研究能够开发出新方法以重置ESRD中的免疫反应,并有助于预防心血管疾病和致命感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NEAL B BLATT其他文献

NEAL B BLATT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NEAL B BLATT', 18)}}的其他基金

Immune Dysregulation in Uremia
尿毒症的免疫失调
  • 批准号:
    8383201
  • 财政年份:
    2012
  • 资助金额:
    $ 15.34万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Preserving Physical Function in Older Adults with Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
保留患有癌症的老年人的身体功能:手术前后应用优化营养干预的影响
  • 批准号:
    10643468
  • 财政年份:
    2023
  • 资助金额:
    $ 15.34万
  • 项目类别:
PediQUEST ResPOND: Piloting an intervention to treat recurrent pain in children with severe neurological impairment
PediQUEST ResPOND:试点干预措施治疗严重神经损伤儿童的复发性疼痛
  • 批准号:
    10606777
  • 财政年份:
    2023
  • 资助金额:
    $ 15.34万
  • 项目类别:
Wicked Smart Pad: Washable Sensorized Bedding for the Prevention and Detection of Moisture Events
Wicked Smart Pad:可清洗的感应床上用品,用于预防和检测潮湿事件
  • 批准号:
    10601816
  • 财政年份:
    2023
  • 资助金额:
    $ 15.34万
  • 项目类别:
A novel intervention to improve care for older sexual and gender minority (SGM) adults with serious illness and especially those with Alzheimer’s Disease and Related Dementias (ADRD)
一种新的干预措施,旨在改善对患有严重疾病的老年性和性别少数 (SGM) 成年人,特别是患有阿尔茨海默氏病和相关痴呆症 (ADRD) 的老年人的护理
  • 批准号:
    10700800
  • 财政年份:
    2022
  • 资助金额:
    $ 15.34万
  • 项目类别:
Algorithm for the Real-Time Detection of Absence Seizures from Oculometric Data
根据眼科数据实时检测失神发作的算法
  • 批准号:
    10421230
  • 财政年份:
    2021
  • 资助金额:
    $ 15.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了